Post by icemandios on Oct 18, 2022 19:34:58 GMT
Asensus Surgical, Inc. To Present at The LD Micro Main Event XV
Presentation on Tuesday, October 25 at 8:30 am PT
Research Triangle Park, North Carolina--(Newsfile Corp. - October 18, 2022) - Asensus Surgical, Inc. (NYSE American: ASXC), Asensus Surgical, a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, announced today that it will be presenting at the 15th annual Main Event on Tuesday, October 25th at 8:30 AM PT at the Luxe Sunset Boulevard Hotel. Shameze Rampertab, Executive Vice President and Chief Financial Officer will be giving the presentation.
Event: LD Micro Main Event XV
Date: Tuesday, October 25, 2022
Time: 8:30 AM PT
Register to watch the virtual presentation here.
The 2022 LD Micro Main Event XV will be held at the Luxe Sunset Boulevard Hotel in Los Angeles from October 25th to the 27th. This three-day, investor conference is expected to feature around 200+ companies, presenting in half-hour increments, as well as private meetings.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance Surgical System powered by the Intelligent Surgical Unit (ISU) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com.
Follow Asensus
Email Alerts: ir.asensus.com/email-alerts
LinkedIn:
Twitter: twitter.com/AsensusSurgical
YouTube: www.youtube.com/c/transenterix
Vimeo: vimeo.com/asxc
About LD Micro
LD Micro aims to be the most crucial resource in the micro-cap world. Whether it is the index, comprehensive data, or hosting the most significant events on an annual basis, LD's sole mission is to serve as an invaluable asset for all those interested in finding the next generation of great companies.
Presentation on Tuesday, October 25 at 8:30 am PT
Research Triangle Park, North Carolina--(Newsfile Corp. - October 18, 2022) - Asensus Surgical, Inc. (NYSE American: ASXC), Asensus Surgical, a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, announced today that it will be presenting at the 15th annual Main Event on Tuesday, October 25th at 8:30 AM PT at the Luxe Sunset Boulevard Hotel. Shameze Rampertab, Executive Vice President and Chief Financial Officer will be giving the presentation.
Event: LD Micro Main Event XV
Date: Tuesday, October 25, 2022
Time: 8:30 AM PT
Register to watch the virtual presentation here.
The 2022 LD Micro Main Event XV will be held at the Luxe Sunset Boulevard Hotel in Los Angeles from October 25th to the 27th. This three-day, investor conference is expected to feature around 200+ companies, presenting in half-hour increments, as well as private meetings.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance Surgical System powered by the Intelligent Surgical Unit (ISU) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com.
Follow Asensus
Email Alerts: ir.asensus.com/email-alerts
LinkedIn:
Twitter: twitter.com/AsensusSurgical
YouTube: www.youtube.com/c/transenterix
Vimeo: vimeo.com/asxc
About LD Micro
LD Micro aims to be the most crucial resource in the micro-cap world. Whether it is the index, comprehensive data, or hosting the most significant events on an annual basis, LD's sole mission is to serve as an invaluable asset for all those interested in finding the next generation of great companies.